Manufacturing more antimalarial active #pharmaceutical ingredients made in #Nigeria can help improve the availability & supply of essential #malaria medicines for millions of people across West Africa. Learn how we’re working with @WorldBank, @PVAC_NG, @NMEPNigeria & @HSCLimited

Des systèmes réglementaires solides et harmonisés sont le fondement de l'avenir pharmaceutique de l'Afrique. Lors de la conférence #SCOMRA2025, @USPharmacopeia a partagé les enseignements tirés de plus de 20 ans d'expérience en matière de collaboration avec les organismes de

Strong, harmonized regulatory systems are the foundation of Africa’s pharmaceutical future. At #SCOMRA2025, @USPharmacopeia shared insights from our 20+ years of experience collaborating with regulators to increase access to #QualityMedicines across Africa. Learn more:

Today at #SCOMRA2025 – Hear from @USPharmacopeia’s Leigh Verbois alongside experts representing @WHO, @ppbkenya, @SAHPRA1, @AHRI_Et, & others discuss how expanding #bioequivalence capacity can strengthen Africa’s pharmaceutical #ManufacturingEcosystem & enhance regulatory

.#SCOMRA2025 is next week! Join our session on expanding #bioequivalence capacity in Africa. We’ll dive into gaps in BE infrastructure, regulatory alignment, and discuss opportunities for collaboration to ensure access to quality generics. Learn more: https://t.co/cXtoifOO7L

USP is heading to #SCOMRA2025 in Mombasa! Join us next week, where our technical experts will share insights on #RegulatorySystems strengthening, building bioequivalence capacity, & increasing access to #quality medicines. Learn more: https://t.co/cXtoifOO7L @AfricaPHF

USP was excited to join the launch of Africa’s Network of Reliance Labs (NARL) - a milestone for #RegulatoryReliance! Proud to have worked with @AUDA_Health & other partners to help realize this achievement towards safe, quality-assured vaccines & medicines. Learn more about our

#Bioequivalence (BE) studies are essential to assuring #quality generic medicines. Yet Africa has limited capacity to conduct BE studies, in part, because investment cases & business strategies remain unclear. Learn how USP is working to change that: https://t.co/pCBDgfnTMu

Happening today at #CPHIA2025! Our colleague @BethYeager4 and other panelists will discuss ongoing initiatives to expand regional #manufacturing of medical products in Africa. Join the side session to learn more: https://t.co/tZGRVUXG86

USP presented findings of a situational analysis on antimalarial #APIproduction in Nigeria, at a @PVAC_NG workshop focused on enhancing #LocalManufacturing. The recommendations will feed into a roadmap to build stronger #SupplyChains for malaria health commodities in Nigeria.

Don’t miss our side-session at #CPHIA2025 co-hosted by @Unitaid, @AfricaCDC, @MedsPatentPool, & @USPharmacopeia on ongoing initiatives and approaches to ensure sustainable regional pharmaceutical production in Africa. Learn more: https://t.co/puKFjhToeL

Great session today! USP’s @tperrer joined panelists from @AfricaCDC, @SAHPRA1 & @PATHtweets to discuss @UNITAID's RMEA portfolio which tackles barriers across the value chain: supply of starting materials, regulatory strengthening, tech transfer, market shaping, & blended

Today at #AHMTEC2025, our colleague @tperrer and other panelists discuss how African pharmaceutical #manufacturers can use incremental innovation to be first to launch products after patent exclusivity ends. Learn more: https://t.co/o4tpRbFZ3W

We invite all participants at AHMTEC2025 to join us tomorrow as Unitaid, @USPharmacopeia & @PATHtweets unveil our US$50M regional manufacturing portfolio which features MedSuRe Africa and MADE in Africa, and strengthens local manufacturing & advances a more self-reliant Africa.